Business Wire

Takara Bio’s First-to-Market Large-Scale Single-Cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced plans to launch two critical solutions for oncology research. These automated ...
Business Wire

Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable ...
News Medical

Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology

Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...
The Scientist

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

This strategic acquisition combines two innovative spatial biology platforms with Takara Bio’s industry-leading portfolio of single-cell genomics tools. TBUSH is a wholly owned subsidiary of Takara ...
The Scientist

Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR ...
Reuters

Takara Bio Selects AGC Biologics As Manufacturer Of Plasmid DNA Intermediate For A Vaccine Against COVID-19

* AGC BIOLOGICS - PARTNERSHIP WITH TAKARA BIO BY COLLABORATING ON PROPHYLAXIS DNA VACCINE, WITH AGC MANUFACTURING PLASMID DNA INTERMEDIATE FOR VACCINE Source text for Eikon: Further company coverage: ...
Morningstar

Takara Bio USA, Inc. Brings New Class of Spatial Technology to Archival Samples with FFPE-Ready Kit

New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc. (“Takara Bio USA”), ...
Computerworld

Takara Bio to mass produce microarray DNA fragments

Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...
technologynetworks

Takara Bio USA

Takara Bio USA is a wholly-owned subsidiary of Takara Bio who manufactures and distributes research-use-only (RUO) kits, reagents and instruments for the life sciences, including next-generation ...
BioWorld

Takara Bio develops novel AAV vector with high gene transfer efficiency to inner ear

Takara Bio Inc. has announced the development of a novel adeno-associated virus (AAV) vector, Sonuaav, which exhibits high gene transfer efficiency into inner ear tissues, with a collaborator at ...
Labroots

Takara Bio USA, Inc

For over 50 years, Takara Bio has been committed to helping scientists break new ground with our innovative technologies. Our extensive portfolio of reagents, instruments, and services support ...